Australia's largest stock trading and investment forum Australia's #1 stock forum

CYP

Click for more information

10.0%

27.5¢ cynata therapeutics limited

Ann: Appendix 4D & Half-Year Financial Statements, page-42

First 42 Last

Share
Profile

Follow
Sector

35,472 Posts.

2863

03/03/23

10:04

Post #: 66578202
Share

Originally posted by Pledge: ↑

Ok, here we go.....

Cash = $16.4M
Commitments for next 12 months approx = $4M
Costs outside of R&D and marketing approx = $4.4M

Pledge's estimate costs needed in the next 12 months to commence the GVHD P2 FDA trial only (nothing else) = $8M (inclusive of US exchange rate).

If CYP deliver on the GVHD promise and aren't able to get anyone to pay for the trial, then there is $0 in 12 months.

Notes:

1. I am being conservative. And broad - I have not touched any other costs.
2. I actually believe they will need AU$10M to deliver on the promise of the GVHD P2 FDA trial (I rounded down). I also think doing it remotely will add another 30% to that but let's run with what we have.
3. At record lows a CR in the next 12 months would be disastrous.
4. Given all of the above at best you come out of this with $0 and a completed P2 trial.
5. I would be asking how the hunt for a sponsor to pay for the promises is going? Not much of a mention in this report for something that is critical.
6. I wish shareholders luck. Even Hector.

Expand

@Pledge
lots of homework there on GvHD costs next 12 months for a trial you have claimed for well over a year was never going to happen

Interesting

No Office

Mark it down

Last edited by Sector: 03/03/23

CYP Price at posting: 29.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

FFM

Firefly positioned for copper growth in Canada ahead of resource update

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 111 more messages in this thread...

First 42 Last

Add CYP (ASX) to my watchlist

(20min delay)
Last 27.5¢		Change 0.025(10.0%)		Mkt cap ! $49.68M

Open	High	Low	Value	Volume
27.5¢	28.0¢	26.0¢	$21.04K	77.98K

Buyers (Bids)

No.	Vol.	Price($)
4	157000	26.0¢

Sellers (Offers)

Price($)	Vol.	No.
27.5¢	4297	1

View Market Depth

No.	Vol.	Price($)
4	157000	0.260
3	202278	0.255
7	60586	0.250
1	10000	0.245
3	5542	0.235

Price($)	Vol.	No.
0.275	4297	1
0.280	36931	3
0.285	10000	1
0.290	236000	2
0.295	25028	2

Last trade - 16.10pm 03/10/2024 (20 minute delay)

CYP (ASX) Chart